Skip to main content
Kirk Johnson on Muck Rack

Kirk Johnson

Verified
Seattle
As seen in: MSN, MSN Canada, MSN UK, The New York Times, MSN South Africa, The Wall Street Journal, Wiley Online Library, CNBC, Boston.com, Sydney Morning Herald and
Writer. Runner. Ex-Nytimes. Co-author with the great artist Julie Green of upcoming book, "First Meal," to be published in 2023. kirk.johnson58@gmail.com
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kirk

Contact Kirk, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

What’s hot at the county libraries: April 2026

|
By Kirk Johnson Verified
| Fauquier Times Verified
The future of Fauquier Times now depends on community support. Your donation will help us continue to improve our journalism through in-depth local news coverage and expanded reader engagement.
Open in Who Shared View Duplicates (11) Issue with article?

What’s hot at the county libraries: April 2026

|
By Kirk Johnson Verified
| Prince William Times Verified
Nonfiction books are still one of the best ways to engage with sustained arguments, in-depth analysis of complex issues and detailed, rich narratives of real events. Here are some of the newest nonfiction books Prince William Public Libraries has to offer. Columbia Law professor Tim Wu is an established writer on tech issues, and even if you don’t recognize the name, you’ve likely heard of the concept of “net neutrality,” a term he coined.
Open in Who Shared Issue with article?

Galcanezumab reduces trigeminal nociception and is effective in preclinical models of migraine and trigeminal autonomic cephalalgias

|
By Marta Vila-Pueyo, Peter J Goadsby, Kirk Johnson Verified
| Wiley Online Library Verified
CGRP calcitonin gene-related peptide SSN superior salivatory nucleus TAC trigeminal autonomic cephalalgia TCC trigeminocervical complex WDR wide dynamic range INTRODUCTION Galcanezumab is a humanized monoclonal antibody that binds to the neuropeptide calcitonin gene-related peptide (CGRP), inhibiting its biological activity.1 Clinical studies have demonstrated its efficacy as a preventive treatment for episodic and chronic migraine and for treatment of episodic cluster headache, leading to...
Open in Who Shared Issue with article?
See all 568 licensed articles (589 Total)